The role of free radicals in endogenous adaptation and intracellular signals

Experimental and Clinical Cardiology

Volumn 9, Issue 1, 2004, Pages 13-16

  Roth E ^a   Hejjel, L ^a   Jaberansari, M T ^a   Jancso, G ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Endogenous adaptation; Free radicals; Ischemic preconditioning; Signal transduction

Indexed keywords

ANTIOXIDANT; FREE RADICAL; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE SYNTHASE; OXYGEN RADICAL; PROSTAGLANDIN SYNTHASE; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTATION; ANTIOXIDANT ACTIVITY; CELL ACTIVITY; CELL DEATH; CELL PROTECTION; DEGENERATIVE DISEASE; DOG; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RABBIT; REVIEW; SIGNAL TRANSDUCTION; SYMPTOM;

EID: 2942641842     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal injury in ischemic myocardium. Circulation 1986;74:1124-36.
2. Lin AM, Dung SW, Chen CF, Chen WH, Ho LT. Hypoxic preconditioning prevents cortical infarction by transient focal ischemia-reperfusion. Ann N Y Acad Sci 2003;993:168-78; 195-6.
3. Dembinski A, Warzecha Z, Ceranowicz P, et al. Ischemic preconditioning reduces the severity of ischemia/reperfusion-induced pancreatitis. Eur J Pharmacol 2003;473:207-16.
4. Fernandez L, Heredia N, Peralta C, et al. Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation. Transplantation 2003;76:282-9.
5. Wang SF, Li GW. Early protective effect of ischemic preconditioning on small intestinal graft in rats. World J Gastroenterol 2003;9:1866-70.
6. Badhwar A, Dungey AA, Harris KA, et al. Limitations of ischemic tolerance in oxidative skeletal muscle: Perfusion vs tissue protection. J Surg Res 2003;109:62-7.
7. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours following brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-72,
8. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acqusition of tolerance to ischemia. Circ Res 1993;72:1293-9.
9. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: Reperfusion-induced arrhythmias. Am J Physiol 1987;253:H1470-6.
10. Vegh A, Papp JG, Parratt JR. Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20h after rapid cardiac pacing. Br J Pharmacol 1994;113:1081-2.
11. Becker J, Mezger W, Courgeon AM, Best-Belpomme M. On the mechanism of action of H2O2 in the cellular stress. Free Radic Res Commun 1991;12-13:455-60.
12. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 1987;84:1404-7.
13. Kloner RA, Pryzyklenk K, Whittaker P. Deleterious effects of oxygen free radicals in ischemia/reperfusion. Circulation 1989;80:1115-27.
14. Murry CE, Richard VJ, Jennings RB, Reimer KA. Preconditioning with ischemia: Is the protective effect mediated by free radical induced myocardial stunning? Ciculation 1988;78(Suppl II):77.
15. Tanaka M, Fujiwara H, Yamasaki K, Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischemic preconditioning in the rabbit. Cardiovasc Res 1994;28:980-6.
16. Osada M, Takeda S, Sato T, Komori S, Tamura K. The protective effect of preconditioning on reperfusion induced arrhythmias is lost by treatment with superoxide dismutase. Jpn Circ 1994;58:259-63.
17. Iwamoto T, Miura T, Adachi T, et al. Myocardial infarct size limiting effect of ischemic preconditioning was not attenuated by oxygen free-radical scavengers in the rabbit. Circulation 1991;83:1015-22.
18. Roth E, Jaberansari MT. Reactive oxygen species in early and delayed cardiac adaptation. Exp Clin Cardiol 2001;6:81-6.
19. Roth E, Jaberansari MT, Jorgensen JJ. Should reperfusion injury be always regarded as deleterious? The up-side of oxidative stress. Perfusion 2000;13:370.
20. Richard V, Tron C, Thuillez C. Ischemic preconditioning is not mediated by oxygen derived free radicals in rats. Cardiovasc Res 1993;27:2016-21.
21. Roth E, Hejjel L. Oxygen free radicals in heart disease. In: Pugsley MK, ed. Cardiac Development Guide. Totowa: Humana Press Inc, 2003:47-66.
22. Maulik N, Sato M, Price BD, Das DK. An essential role of NFkB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998;429:365-9.
23. Morgan EN, Boyle EM Jr, Yun W, et al. An essential role for NF-kappaB in the cardioadaptive response to ischemia. Ann Thorac Surg 1999;68:377-82.
24. Dana A, Jonassen AK, Yamashita N, Yellon DM. Adenosine A1 receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation 2000;101:2841.
25. Shinmura K, Tang XL, Wang Y, et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 2000;97:10197-202.
26. Guo Y, Jones WK, Xuan Y-T, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 1999;96:11507.
27. Zahler S, Kupatt C, Becke BF. Endothelial preconditioning by transient oxidative stress reduces inflammatory responses of cultured endothelial cells to TNF-alpha. FASEB 2000;14:555-64.
28. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-72.
29. Carter DA. Modulation of cellular AP-1 DNA binding activity by heat shock proteins. FEBS Lett 1997;416:81-5.
30. Maulik N, Sato M, Price BD, Das DK. An essential role of NFkB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998;429:365-9.
31. Downey JM, Liu GS, Thornton JD. Adenosine and the anti infarct effects of preconditioning. Cardiovasc Res 1993;27:3-8.
32. ATP channels. Am J Heart Circ Physiol 1998;43:H909-14.
33. Eskildsen-Helmond YEG, Gho BCG, Bezstarosti K, et al. Exploration of possible rotes of phospholipase D and protein kinase C in the mechanism of preconditioning in the myocardium. Ann N Y Acad Sci 1996;793:210-25.
34. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 1994;276:H1229-35.
35. Bolli R, Manchikalapudi S, Tang XL, et al. The protective effects of late preconditioning against myocardial stunning in conscious rabbits are mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 1997;81:1094-107.
36. Vondriska T, Zhang J, Song C, et al. PKCepsilon-SRC modules direct signal transduction in NO-induced cardioprotection: Complex formation as a means for cardioprotective signaling. Circ Res 1999;88:1306-13.
37. Xuan Y-T, Tang X-L, Qiu Y, et al. Biphasic response of cardiac NO synthase to ischaemic preconditioning in conscious rabbits. Am J Physiol 2000;279:H2360-71.
38. Valen G, Yan Z-Q, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001;38:307-14.
39. Mercurio F, Manning AM. NF-kB as a primary regulator of the stress response. Oncogene 1999;18:6163-71.
40. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 1990;82:2044-51.
41. The ISIS-4 investigators. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
42. Claeys MJ, Vrints CJ, Bosmans JM, Conraads VM, Snoeck JP. Aminophylline inhibits adaptation to ischemia during angioplasty. Role of adenosine in ischemic preconditioning. Eur Heart J 1996;17:539-44.
43. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997;95:2500-7.
44. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-7.
45. Perrault LP, Menaschè P, Bel A, et al. Ischemic preconditioning in cardiac surgery: A word of caution. J Thorac Cardiovasc Surg 1996;112:1378-86.
46. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997;77:314-8.
47. Mentzer RM, Rahko PS, Molina-Viamonte V, et al. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol 1997;79:38-43.
48. Menasché P, Jamieson WRE, Flameng W, Davis MK. Acadesine: A new drug that may improve myocardial protection in coronary artery bypass grafting (CABG). J Thorac Cardiovasc Surg 1995;110:1096-106.